Cadence Neuroscience’s $26 Million Series B Financing

Fenwick represented Cadence Neuroscience on the deal.Cadence Neuroscience, a medical device company, announced that it has secured $26 million in Series B financing. The round was led by Angelini…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here